Anne McGeorge insider trades: Dianthus Therapeutics (DNTH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anne reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | DNTH | ↓ Sell | 7,750 | $109.01 | $845K | Direct | Aug 11, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DNTH insiders
Open-market trades in the last 12 months
About Anne McGeorge's insider trades
Anne McGeorge is an insider at Dianthus Therapeutics (DNTH). Since Aug 10, 2026, Anne has reported no open-market purchases and 1 sale worth $845K on SEC Form 4. In the last 12 months: 1 sale ($845K).
Their filings also include grants and awards (17 filings), option exercises (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.